https://www.selleckchem.com/pr....oducts/ro5126766-ch5
003, 0.006, 0.005 and 0.000, respectively). Of all recurrences, 34.1% were explained by HSIL and increased PLR and SII values. The prediction of CA recurrence is important to determine those patients at high risk. PLR and SII can be used for risk analysis in selected patient groups. Sample-size estimation is an important factor in designing a clinical trial. A recent study found that 65% of Cochrane systematic reviews had imprecise results. This study set out to review the whole body of inflammatory bowel disease (IBD) rando
Like
Comment
Share
